4Lieber CS. CYP2E1: from ASH to NASH[J]. Hepatol Res, 2004, 28: 1-11. 被引量：1
5Brownlee M. The pathobiology of diabetic complications: a unifying mechanism[J]. Diabetes,2005, 54: 1615-1625. 被引量：1
6Angulo P, Keach JC, Batts KP, et al. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis[J]. Hepatology, 1999, 30 : 1356-1362. 被引量：1
7Castro Cabezas M, Erkelens DW, van Dijk H. Free fatty acids: mediators of insulin resistance and atherosclerosis[J]. Ned Tijdschr Geneeskd, 2002,146 : 103-109. 被引量：1
8Yuan M, Konstantopoulos N, Lee J, et al. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta[J]. Science,2001,293: 1673-1677. 被引量：1
9Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference[J]. Hepatology, 2003,37 : 1202-1219. 被引量：1
10Liu H, Jones BE, Bradham C, et al. Increased cytochrome P- 450 2E1 expression sensitizes hepatocytes to c-Jun-mediated cell death from TNF alpha [J]. Am J Physiol Gastrointest Liver Physiol, 2002,282: G257-266. 被引量：1
